
Digistain nominated for the EIT Awards 2026
Digistain has been nominated for the EIT Awards 2026 in the Venture Award category. The Venture Award recognises organisations combining strong commercial potential with meaningful

Digistain has been nominated for the EIT Awards 2026 in the Venture Award category. The Venture Award recognises organisations combining strong commercial potential with meaningful

In September 2026 Sasha Becejac, Digistain’s CCO, was invited to speak at On Targeted Molecular Oncology 2026 in Ankara, Türkiye, sharing the latest developments around

In September 2026 Sarah Bond, our COO for the MENA region, took part in The Future Health Dialogue roundtable hosted at Hub71 in Abu Dhabi,

In July 2026 co-founder Professor Chris Phillips and COO Sabrina Ali met clinicians, researchers and pathology teams at major hospitals and innovation centres in Shanghai,

In February 2026 Digistain was selected as one of 27 companies by the EUREKA Investment Readiness Network to join a mission to South Summit Brazil,

In March 2026 we announced that Digistain has secured the rights to distribute geneType® across Southeast Asia. geneType is developed by Rhythm Biosciences, a publicly

In March 2026 Digistain was represented at the Thailand Board of Investment roundtable at the Thai Embassy in London. The evening brought together leaders from

In December 2025 we showcased Digistain at BIGOSA 2025 alongside our partner, the Key Oncologics team. We engaged with hundreds of delegates and shared our

In our ongoing effort to bring accessible cancer diagnostics to the regions that need them most, we are proud to announce the official launch of

We are thrilled to share that Digistain was hand selected by an expert panel of judges from EIT Health, AstraZeneca Spain, SERMAS and Hospital 12

It was an honour to take part in the recent Physics Deep Tech Showcase at Institute of Physics, hosted in partnership with the Venture Capital

We’re proud to share that Digistain® was featured in the Startup Spotlight at Onco:Innovate 2025 as part of ViennaUp, recognised among the leading innovators transforming
To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |